Literature DB >> 35749032

Chronic high-fat diet consumption exacerbates pyroptosis- and necroptosis-mediated HMGB1 signaling in the brain after ischemia and reperfusion injury.

Nuttapong Yawoot1,2, Wijitra Chumboatong1, Jirakhamon Sengking3, Chainarong Tocharus3, Jiraporn Tocharus4,5.   

Abstract

Obesity is categorized as a common comorbidity found in people who experience an ischemic stroke. However, the mechanisms to explain this correlation have still not been elucidated fully. Pyroptosis and necroptosis are novel forms of programmed cell death that occur upon intracellular danger signals. The major feature of pyroptosis and necroptosis is damage to the lipid membrane, which consequently results in lytic cell death and allows the release of high mobility group box protein 1 (HMGB1) into the extracellular space. We aimed to investigate the influences of high-fat diet (HFD) consumption on cerebral ischemia and reperfusion (I/R) injury and hypothesized that HFD consumption exacerbated the activation of pyroptosis, necroptosis, and HMGB1 signaling pathways. All rats received normal diet (ND) or HFD for 16 weeks. Subsequently, both groups were divided into either a sham- or an I/R-operated group. Twenty-four hours after the surgery, all rats were evaluated for neurological deficits and then sacrificed. After I/R injury, there were more severe functional deficits and larger brain infarcts in the HFD compared with the ND group. The histological observation revealed an increase in tissue abnormalities in the HFD group, consistent with the massive reduction of intact neurons along the peri-infarct region. Furthermore, cerebral I/R injury dramatically activated the pyroptotic, necroptotic, and HMGB1 signaling pathways in HFD-fed rats compared with ND-fed rats. These findings suggest that chronic HFD consumption worsens ischemic brain pathology and leads to poor post-stroke outcomes by exacerbating pyroptotic and necroptotic cell death.
© 2022. The Author(s) under exclusive licence to University of Navarra.

Entities:  

Keywords:  Cerebral ischemia; High-fat diet; Necroptosis; Neuroinflammation; Obesity; Pyroptosis

Year:  2022        PMID: 35749032     DOI: 10.1007/s13105-022-00906-4

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  32 in total

1.  Relationship of obesity to recanalization after hyperacute recombinant tissue-plasminogen activator infusion therapy in patients with middle cerebral artery occlusion.

Authors:  Ichiro Deguchi; Yasuko Ohe; Takuya Fukuoka; Tomohisa Dembo; Harumitsu Nagoya; Yuji Kato; Hajime Maruyama; Yohsuke Horiuchi; Norio Tanahashi
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-01-30       Impact factor: 2.136

2.  Ischemia-Reperfusion Injury After Endovascular Thrombectomy for Ischemic Stroke.

Authors:  Maxime Gauberti; Bertrand Lapergue; Sara Martinez de Lizarrondo; Denis Vivien; Sébastien Richard; Serge Bracard; Michel Piotin; Benjamin Gory
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 3.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

4.  NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes.

Authors:  Sorina Georgiana Boaru; Erawan Borkham-Kamphorst; Eddy Van de Leur; Eric Lehnen; Christian Liedtke; Ralf Weiskirchen
Journal:  Biochem Biophys Res Commun       Date:  2015-02-14       Impact factor: 3.575

5.  The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men.

Authors:  Juan F Arenillas; Patricio Sandoval; Natalia Pérez de la Ossa; Mónica Millán; Cristina Guerrero; Domingo Escudero; Laura Dorado; Elena López-Cancio; José Castillo; Antoni Dávalos
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

6.  Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling.

Authors:  Xu-Xu Deng; Shan-Shan Li; Feng-Yan Sun
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

Review 7.  Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.

Authors:  Aishika Datta; Deepaneeta Sarmah; Leela Mounica; Harpreet Kaur; Radhika Kesharwani; Geetesh Verma; Pabbala Veeresh; Vignesh Kotian; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Transl Stroke Res       Date:  2020-03-26       Impact factor: 6.829

Review 8.  Pyroptosis versus necroptosis: similarities, differences, and crosstalk.

Authors:  Daniel Frank; James E Vince
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

9.  The effect of focal cerebral ischemia-reperfusion injury on TLR4 and NF-κB signaling pathway.

Authors:  Jing Chen; Chenli Yang; Xiang Xu; Yonglin Yang; Bo Xu
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

Review 10.  Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life.

Authors:  Eric S Donkor
Journal:  Stroke Res Treat       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.